Guest guest Posted May 5, 2008 Report Share Posted May 5, 2008 PCRI is pleased to announce: The PROSTATE CANCER CONFERENCE - 2008 State-of-the-Art Treatments for Early Stage and Relapsed Prostate Cancer SEPTEMBER 6-7 Sheraton Gateway Hotel Los Angeles Airport, California FOR DETAILS AND REGISTRATION - www.pcri.org EARLY STAGE DISEASE The first part of the conference will focus on early stage disease. ** MARK MOYAD MD, a leading alternative medicine expert at University of Michigan, will de-mystify the situation on dietary supplements. ** PETER CARROLL MD, Professor and Chair of Urology at UCSF, the host of last year's first-ever International Conference on Active Surveillance, will present the latest thinking on this popular alternative to immediate treatment. ** RICHARD BABAIAN MD, Professor of Urology from MD , will be presenting his research into using the new PCA-3 urine test to estimate if a man's tumor is small enough for safe monitoring. ** DUKE BAHN MD, the Director of the Prostate Institute of America will give us an overview of the latest on focal therapy - treatment aimed specifically at the tumor inside the prostate instead of attempting to destroy the whole gland with surgery or radiation. ** VERNE VARONA, the author of Nature's Cancer Fighting Foods will explain how to inhibit cancer with an optimal diet. ** DANIEL MARGOLIS MD, Assistant Professor of Radiology at UCLA, will share the latest information on imaging prostate cancer. RELAPSED DISEASE Studies show that testosterone deprivation therapy is remarkably effective; on average, it controls prostate cancer for eleven years after a relapse occurs. However, the side effects of testosterone blockade multiply as treatment duration is extended. ** STEPHEN STRUM MD, Medical Oncologist and one of the authors of the A Primer on Prostate Cancer, will discuss the optimal approach to intermittent hormone blockade. ** MARK SCHOLZ MD, the executive director of the PCRI, will summarize the latest research on new, less toxic treatments that can be used in lieu of hormone therapy. ** MICHAEL STEINBERG MD, the Director of Radiation Therapy at UCLA, will inform how state-of-the-art radiation can in some cases cure relapsed disease. ADVANCED DISEASE ** CHARLES " SNUFFY " MYERS MD, Director of the American Institute for Disease of the Prostate, will be addressing the treatment of oligo-metastasis, speaking about innovative methods aimed at curing minimal metastatic disease. ** RICHARD LAM MD, the Director of Research at Prostate Oncology Specialists, will address the question, " What are the most effective of chemotherapy combinations? " ** NICHOLAS VOGELZANG MD, Director of the Nevada Cancer Institute will be discussing more accurate ways to monitor advanced disease and non-chemotherapy treatments. ** HOWARD SOULE PhD, the Chief Scientific Officer for the Prostate Cancer Foundation, the largest philanthropic research foundation for prostate cancer in the world, will talk about the latest discoveries. THIS CONFERENCE IS FOR YOU. DON'T MISS IT While the presentations are the foremost attractions of the conference, there are other conference events that should be of interest to you and your family as well as caregivers, medical professionals - indeed anyone involved in prostate cancer matters. For example, you can interact with speakers after every presentation; you can submit questions relating to your own personal situation for a panel discussion; you can examine exhibits and talk with participating supporters; and you can interact with other PC patients with experiences and situations like yours. UsTOO, the largest support group network in the country, will be conducting meetings throughout the conference so men and spouses can connect with others facing the same challenges. PCRI INTRODUCES THE HARRY PINCHOT AWARDS A special highlight will be the presentation of the first " Harry Pinchot Awards " for " Exemplary Service to the Prostate Cancer Community " . See the PCRI website for details on how to nominate an individual for this award. The conference is produced by the Prostate Cancer Research Institute in partnership with National Prostate Cancer Coalition, Patient Advocates for Advanced Cancer Treatments (PAACT), Prostate Cancer Foundation and UsTOO. -- Sincerely, Jim O'Hara PC Survivor since 1996 PCRI Educational Facilitator (in Georgia) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.